Quarterly ResultJun 22, 2026, 05:02 PM
BIO-key Q1 Revenue +33.5%, Net Loss Narrows; Reverse Stock Split
AI Summary
BIO-key International reported a significant improvement in its first-quarter 2026 financial results, with total revenues increasing by 33.5% to $2.15 million and net loss narrowing to $0.21 million from $0.74 million in Q1 2025. Despite these improvements, the company raised substantial doubt about its ability to continue as a going concern due to historical losses and negative cash flow. The company also completed a 1-for-10 reverse stock split effective April 30, 2026.
Key Highlights
- Total revenues increased 33.5% to $2.15 million in Q1 2026.
- Net loss narrowed to $0.21 million in Q1 2026 from $0.74 million in Q1 2025.
- Basic and diluted loss per share improved to $(0.20) from $(1.57).
- Company completed a 1-for-10 reverse stock split on April 30, 2026.
- Raised substantial doubt about ability to continue as a going concern.
- Cash and cash equivalents were $2.25 million as of March 31, 2026.
- License fees revenue increased to $1.37 million from $1.10 million.
- Hardware revenue increased to $0.53 million from $0.24 million.
Price Impact
More from BKYI